Clinical Trials Directory

Trials / Sponsors / Guardant Health, Inc.

Guardant Health, Inc.

Industry · 9 registered clinical trials — 3 currently recruiting.

StatusTrialPhaseStarted
RecruitingShield Post-Approval Study Protocol
Colo-rectal Cancer
—2025-07-14
RecruitingSIBYL: obServation of Therapy Response With lIquid BiopsY evaLuation
Non-small Cell Lung Cancer, Colorectal Cancer, Breast Cancer
—2023-10-25
Active Not RecruitingScreening for High Frequency Malignant Disease
Lung Cancer
—2022-01-13
RecruitingORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Bladder Carcinoma, Ureter Carcinoma, Renal Pelvis Carcinoma
—2021-09-07
CompletedGuardant360® Related Clinical Outcomes in Patients Who Share Medical Records-Breast Cancer
Advanced Breast Cancer
—2020-07-02
CompletedEvaluation of the ctDNA LUNAR Test in an Average Patient Screening Episode
Colorectal Cancer
—2019-10-08
CompletedGuardant360® Test-Related Clinical Outcomes in Patients Who Share Medical Records
Non-Hematologic Malignancy
—2019-04-30
TerminatedRegistry of Guardant360® Use and Outcomes In People With Advanced Cancer
Non-small Cell Lung Cancer Metastatic
—2018-04-06
CompletedNoninvasive vs. Invasive Lung Evaluation
Non-Small Cell Lung Cancer
—2016-02-12